Recent studies have reported a relationship between the platelet to lymphocyte ratio (PLR) and acute coronary syndromes. The aim of the present study was to investigate the association between PLR and stable coronary artery disease (CAD). A systematic search was conducted based on electronic databases (Cochrane, PubMed, Elsevier, Medline, and Embase). A total of 14 studies (n = 4,871) were included in the meta-analysis. Compared with the non-CAD group, PLR was significantly higher in CAD group (P = .002). After further classification according to the Gensini score, the cases with atherosclerosis demonstrated a higher PLR than those without atherosclerosis (P < .001). Platelet to lymphocyte ratio was higher in the severe atherosclerosis group compared with the mild atherosclerosis group (P < .001). Compared with the poor coronary collateral circulation (CCC) group, PLR was significantly lower in the good CCC group (P < .001). The PLR was significantly higher in patients with coronary slow flow (CSF) than those with normal coronary flow (P = .01). On the basis of current evidence, an elevated PLR was associated with stable CAD, and it might be useful for predicting CAD severe stenosis, collateral circulation, and CSF. Future studies are needed to clarify the relationship between PLR and stable CAD.
NguyenMTFernandoSSchwarzNTanJTBursillCAPsaltisPJ. Inflammation as a therapeutic target in atherosclerosis. J Clin Med. 2019;8:1109.
2.
LiuYJiaSDYaoY, et al.Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. J Cardiol. 2019;75:30222–9.
3.
MayerFJGruenbergerDSchillingerM, et al.Pro gnostic value of neutrophils in patients with asymptomatic carotid artery disease. Atherosclerosis. 2013;231:274–80.
4.
ShenXHChenQShiYLiHW. Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Chin Med J (Engl). 2010;123:3438–43.
5.
MrazMCinkajzlovaAKlouckovaJ, et al.Coronary artery disease is associated with an increased amount of t lymphocytes in human epicardial adipose tissue. Mediators Inflamm. 2019;2019:4075086.
6.
ZeibigSButtcherMGoebelS, et al.The scavenger receptor cd68 regulates platelet mediated oxidized low-density lipoprotein (oxLDL) deposition in atherosclerotic vessels at an early stage of atherosclerosis in LDLR(-/-)/apobec(-/-) mice. Cell Physiol Biochem. 2019;52:681–95.
7.
YangGChenL. An update of microsomal prostaglandin e synthase-1 and pge2 receptors in cardiovascular health and diseases. Oxid Med Cell Longev. 2016;2016:5249086.
8.
Palur RamakrishnanAVVargheseTPVanapalliSNairNKMingateMD. Platelet activating factor: A potential biomarker in acute coronary syndrome?Cardiovasc Ther. 2017;35:64–70.
9.
NunezJSanchisJBodiV, et al.Therapeutic implications of low lymphocyte count in non-ST segment elevation acute coronary syndromes. Eur J Intern Med. 2009;20:768–74.
10.
KurtulAMuratSNYarliogluesM, et al.Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes. Am J Cardiol. 2014;114:972–8.
11.
LiWLiuQTangY. Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: a meta-analysis. Sci Rep. 2017;7:40426.
12.
LiHZhouYMaYHanSZhouL. The prognostic value of the platelet-to-lymphocyte ratio in acute coronary syndrome: a systematic review and meta-analysis. Kardiol Pol. 2017;75:666–73.
13.
AkbogaMKCanpolatUYaylaC, et al.Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2015;67:89–95.
14.
KoseNAkinFYildirimTErgunGAltunI. The association between the lymphocyte-to-monocyte ratio and coronary artery disease severity in patients with stable coronary artery disease. Eur Rev Med Pharmacol Sci .
2019;23:2570–5.
15.
YukselMYildizAOylumluM, et al.The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2015;15:640–7.
16.
UcarFMAcarBGulMOzekeOAydogduS. The association between platelet/lymphocyte ratio and coronary artery disease severity in asymptomatic low ejection fraction patients. Korean Circ J. 2016;46:821–6.
17.
OzdemirSBarutcuAGaziETanYZTurkonH. The relationship between some complete blood count parameters and myocardial perfusion: a scintigraphic approach. World J Nucl Med. 2015;14:197–201.
18.
SariISunbulMMammadovC, et al.Relation of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography. Kardiol Pol. 2015;73:1310–6.
19.
SharmaKPatelAKShahKHKonatA. Is neutrophil-to-lymphocyte ratio a predictor of coronary artery disease in western Indians?Int J Inflamm. 2017;2017:4136126.
20.
ZhouDWangGFanYWanZLiuX. Platelet to lymphocyte ratio is associated with the severity of coronary artery disease and clinical outcomes of percutaneous coronary intervention in the Chinese Han population. Exp Ther Med. 2017;13:731–8.
21.
AcarGKalkanMEAvciA, et al.The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Clin Appl Thromb Hemost. 2013;21:462–8.
22.
AkdagSAkyolAAskerMOzturkFGumrukcuogluHA. The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with non-ST segment elevation myocardial infarction. Postepy Kardiol Interwencyjnej. 2016;12:224–30.
23.
AkbogaMKCanpolatUBalciKG, et al.Increased platelet to lymphocyte ratio is related to slow coronary flow. Angiology. 2015;67:21–6.
24.
OylumluMDoganAYildizA, et al.Relationship between platelet-to-lymphocyte ratio and coronary slow flow. Anatol J Cardiol. 2014;15:391–5.
25.
RadwanHGadMGomaaA. Predictors of coronary slow flow in stable coronary artery disease. JACC Cardiovasc Interv. 2017;10:3.S31.
26.
ElalmisOUCetinMIleriM, et al.Predictors of slow coronary flow in a multivariate model. Am J Cardiol. 2014;13e6.
27.
DiemSSchmidSKrapfM, et al.Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017;111:176–81.
28.
ZhuSYangJCuiX, et al.Preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of clinical outcome in patients with gallbladder cancer. Sci Rep. 2019;9:1823.
29.
GungorHBabuASZencirC, et al.Association of preoperative platelet-to-lymphocyte ratio with atrial fibrillation after coronary artery bypass graft surgery. Med Princ Pract. 2016;26:164–8.
30.
SeropianIMRomeoFJPizarroR, et al.Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation. ESC Heart Fail. 2017;5:149–56.
31.
KurtulAOrnekE. Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review. Angiology. 2019;70:802–18.
32.
AnwarIWWijayaIPSukrismanLNasutionSARumendeCM. Diagnostic accuracy of platelet/lymphocyte ratio for screening complex coronary lesion in different age group of patients with acute coronary syndrome. Acta Med Indones. 2018;50:185–92.
33.
YaylaCAkbogaMKCanpolatU, et al.Platelet to lymphocyte ratio can be a predictor of infarct-related artery patency in patients with ST-segment elevation myocardial infarction. Angiology. 2015;66:831–6.
34.
ImhofBAAurrand-LionsM. Angiogenesis and inflammation face off. Nat Med. 2006;12:171–2.
35.
CetinMKiziltuncEElalmisOU, et al.Predictive value of neutrophil lymphocyte ratio and platelet lymphocyte ratio in patients with coronary slow flow. Acta Cardiol Sin. 2016;32:307–12.
36.
YaylaCCanpolatUAkyelA, et al.Association between platelet to lymphocyte ratio and saphenous vein graft disease. Angiology. 2016;67:133–8.
37.
LiCShenYXuR, et al.evaluation of preprocedural laboratory parameters as predictors of drug-eluting stent restenosis in coronary chronic total occlusion lesions. Angiology. 2019;70:272–8.
